Innovators in Discovery
As a physician scientist and leader in the development of targeted therapies for cancer, Dr. Sawyers investigates the signaling pathways that drive the growth and drug resistance of cancer cells.
A renowned authority on hormones and their role in disease, Dr. Evans has conducted research that has led to the discovery of nearly 50 nuclear hormone receptors.
Dr. Horwitz's contributions to the field encompass agents that have served as prototypes for some of the most important drugs currently in clinical use. Her most seminal contribution has been in the development of Taxol®, a drug isolated from the yew plant, Taxus brevifolia.
An internationally recognized leader in clinical and translational research on breast cancer, Dr. Garber developed one of the first cancer risk and prevention clinics where programs are now being expanded to several types of cancer.
Fellow of the AACR Academy John E. Dick, PhD, earns the 2020 Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research.
Physician-scientist and Fellow of the AACR Academy William N. Hait, MD, PhD, encourages collaborations to intercept, prevent, and treat cancer. Throughout a varied career in academia and industry, Dr. Hait has kept his sights on benefiting patients.
A leader in the study of how mutations affecting tumor-suppressor genes cause cancer, Dr. Kaelin's research has had major clinical implications for several forms of cancer, particularly kidney cancer. Dr. Kaelin, Sir Peter J. Ratcliffe, MD, FRS, and Gregg L. Semenza, MD, PhD, were awarded the 2019 Nobel Prize in Physiology or Medicine.
Elaine R. Mardis, PhD, spends a lot of her time studying molecules at the Institute for Genomic Medicine at Nationwide Children’s Hospital in Columbus, Ohio. What she sees is invisible to the naked eye, but her vision for what clinicians can do with the information they find in the genes of a cancer cell is clear.
Dr. Olufunmilayo Olopade, a physician-scientist and director of the Center for Clinical Cancer Genetics at the University of Chicago Medical Center seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
W. Kimryn Rathmell, MD, PhD, director of the Division of Hematology and Oncology at Vanderbilt University Medical Center in Nashville, has twice been awarded grants by the American Association for Cancer Research (AACR). “The AACR does a great job of identifying high-risk, high-reward research,” Dr. Rathmell said.
Your donation to the American Association for Cancer Research helps our more than 50,000 members worldwide drive progress against cancer.
Donate Now